These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12811370

  • 1. [Vasonit retard in the treatment of intermittent claudication in patients with obliterating diseases of the lower extremities].
    Pokrovskiĭ AV, Chupin AV, Kalinin AA, Markosian AA, Zamskiĭ KS, Kolosov RV.
    Angiol Sosud Khir; 2003; 9(2):19-24. PubMed ID: 12811370
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 4. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG, Pini M, Moratti A, Paolicelli M, Basevi P, Quintavalla R, Manotti C, Di Lecce C.
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of a new pentoxifilline form-vasonit retard in the treatment of patients with obliterating diseases of the lower limbs arteries].
    Koshkin VM.
    Ter Arkh; 2005 Apr; 77(4):83-4. PubMed ID: 15938541
    [No Abstract] [Full Text] [Related]

  • 6. [The assessment of TIKLO efficacy in patients with intermittent claudication].
    Zatevakhin II, Zolkin VN, Shiller EE.
    Angiol Sosud Khir; 2007 Apr; 13(2):19-23. PubMed ID: 18004255
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM, Su SF, Tsai CH, Lee YT, Wang SS.
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [Abstract] [Full Text] [Related]

  • 8. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
    Gresele P, Migliacci R, Procacci A, De Monte P, Bonizzoni E.
    Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cilostazol: a replacement for pentoxifylline?
    Shukla V.
    Issues Emerg Health Technol; 1999 Jul; (7):1-4. PubMed ID: 11811214
    [No Abstract] [Full Text] [Related]

  • 11. Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial.
    Incandela L, De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Geroulakos G, Ramaswami G.
    Angiology; 2002 Jul; 53 Suppl 1():S27-30. PubMed ID: 11865832
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic effects of Vascupump treatment patients with Fontaine Stage II B arteriopathy.
    Allegra C, Bartolo M, Martocchia R.
    Minerva Cardioangiol; 2001 Jun; 49(3):189-95. PubMed ID: 11382835
    [Abstract] [Full Text] [Related]

  • 13. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
    Commeau P, Barragan P, Roquebert PO.
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
    [Abstract] [Full Text] [Related]

  • 14. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication.
    Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum Ø, Jørgensen JJ, Lindahl AK, Arnesen H, Seljeflot I, Kroese AJ.
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):3-12. PubMed ID: 17055756
    [Abstract] [Full Text] [Related]

  • 15. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
    Canonico V, Ammaturo V, Guarini P, Tedeschi C, Nunziata G, Nappi A, Forgione L, Rengo F.
    Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
    [Abstract] [Full Text] [Related]

  • 16. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up.
    Wann-Hansson C, Hallberg IR, Risberg B, Lundell A, Klevsgard R.
    J Adv Nurs; 2005 Aug; 51(3):227-35. PubMed ID: 16033590
    [Abstract] [Full Text] [Related]

  • 17. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
    Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K.
    Am Heart J; 2007 May; 153(5):874-80. PubMed ID: 17452167
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pentoxifylline in the nonoperative management of intermittent claudication.
    Kokesh J, Kazmers A, Zierler RE.
    Ann Vasc Surg; 1991 Jan; 5(1):66-70. PubMed ID: 1997079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.